2016
DOI: 10.1007/s10875-016-0292-3
|View full text |Cite
|
Sign up to set email alerts
|

Hemophagocytic Lymphohistiocytosis as a Complication in Patients with MSMD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 5 publications
1
15
0
Order By: Relevance
“…Since the discovery of its first genetic etiology in 1996, MSMD has been reported and a causal genetic lesion described in 501 individuals from 356 kindreds originating from 57 countries on five continents (Figure a). Over this period, the genetic dissection of MSMD in these patients has revealed this condition to be caused by inborn errors of interferon (IFN)‐γ immunity . These findings confirm that IFN‐γ, first described in 1965 as an antiviral IFN, is actually the macrophage‐activating factor, as shown in 1983 .…”
Section: Introductionsupporting
confidence: 61%
See 1 more Smart Citation
“…Since the discovery of its first genetic etiology in 1996, MSMD has been reported and a causal genetic lesion described in 501 individuals from 356 kindreds originating from 57 countries on five continents (Figure a). Over this period, the genetic dissection of MSMD in these patients has revealed this condition to be caused by inborn errors of interferon (IFN)‐γ immunity . These findings confirm that IFN‐γ, first described in 1965 as an antiviral IFN, is actually the macrophage‐activating factor, as shown in 1983 .…”
Section: Introductionsupporting
confidence: 61%
“…Clinical manifestations are, therefore, highly variable. Macrophage activation syndrome or vasculitis may occur in rare cases, probably as a consequence of uncontrolled infection. Since the discovery of its first genetic etiology in 1996, MSMD has been reported and a causal genetic lesion described in 501 individuals from 356 kindreds originating from 57 countries on five continents (Figure a).…”
Section: Introductionmentioning
confidence: 99%
“…Hemophagocytic lymphohistiocytosis has been increasingly reported as an infectious (viral or bacterial) complication in PID defects, including chronic granulomatous disease (X-linked and autosomal recessive), severe-combined immunodeficiency, Wiskott–Aldrich syndrome, DiGeorge anomaly, X-linked agammaglobulinemia, Hyper-IgD syndrome, ectodermal dysplasia with immunodeficiency, autoimmune lymphoproliferative syndrome (FAS-ALPS), cyclic neutropenia, tumor necrosis factor-1 receptor associated periodic syndrome (TRAPS), familial Mediterranean fever, NLRC4; and thus far five patients with defects in the IFN-γ circuit (9, 10). In addition, several monogenic PID diseases have been linked to HLH (11), including the four known genes causing familial HLH ( PRF1, UNC13D, STX11, STXBP2 ), and other defects considered as predisposing to HLH: the partial albinism syndromes with an “accelerated phase”: Griscelli syndrome type 2 ( RAB27A ), Chediak Higashi syndrome ( LYST ), the Hermansky Pudlak syndrome type 2 ( AP3B1 ); and the X-linked lymphoproliferative diseases (both SAP and XIAP deficiencies, caused by SH2D1A and BIRC4 mutations, respectively).…”
Section: Discussionmentioning
confidence: 99%
“…It is generally considered a T-cell disorder of impaired activation (11), to depend on activated NK cells (9), and to be driven by elevated IFN-γ, TNFα, and IL-6 (4). However, IFN-γ receptors are located on macrophages (and elsewhere).…”
Section: Discussionmentioning
confidence: 99%
“…9,11,13,14 However, the role of IFN-g has been recently challenged, with the findings of HLH in patients with genetic defects in the IFN-g pathway. [15][16][17] Specifically, 3 patients have been reported to have HLH disease and an IFN-gR defect, although among these, only 1 patient received a definitive diagnosis of a complete absence of IFN-g signaling through IFN-gR2, whereas the other 2 patients had either a partial or implied defect of IFN-g receptor 1 (IFN-gR1). 15,16 Supporting the IFN-g independence of disease, development of systemic juvenile idiopathic arthritis-like inflammation has been described in Ifng knockout mice.…”
Section: Abbreviations Usedmentioning
confidence: 99%